Moderna said its new flu shot has been cleared for review in Australia, Canada and the European Union. It has asked to meet with the FDA. In May, the U.S. Department of Health and Human Services (HHS) ...
The flu vaccine is its first using mRNA technology for influenza.
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine ...
(The Hill) — Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover ...
Dealbreaker on MSN
Moderna says FDA refusal to review mRNA flu vaccine contradicts federal rules, prior guidance
The FDA’s refuse-to-file letter cited no safety or efficacy concerns for Moderna’s influenza vaccine.
The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...
Moderna’s mRNA influenza vaccine faces US regulatory delays after a refusal-to-file letter from top FDA official Dr Vinay Prasad.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results